This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Six M&A deals approved as Indian regulator bypasses quorum, invokes doctrine of necessity

By Freny Patel ( February 10, 2023, 01:29 GMT | Insight) -- The logjam of merger and acquisition reviews linked to the Indian government’s failure to appoint a new chief of the country’s antitrust agency finally came to an end late Thursday evening as the watchdog cleared six of the 20 pending merger filings. The Competition Commission of India invoked the doctrine of necessity to bypass the required quorum of three commissioners, bringing a sigh of relief to the Indian legal community who were embarrassed as their deals were stuck ever since CCI's former chairman Ashok Kumar Gupta retired in late October.The logjam of merger and acquisition reviews linked to the Indian government’s failure to appoint a new chief of the country’s antitrust agency finally came to an end late Thursday evening as the watchdog cleared six of the 20 pending merger filings....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login